China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015)
China Pharma Holdings' (CPHI) quarterly Construction in Progress came in at $19747.0 in Q3 2015, down 99.84% YoY from $12.5 million in Q3 2014, and up 234.92% on a QoQ basis from $5896.0 in Q2 2015.
China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015) Analysis & Trends
China Pharma Holdings (CPHI) has 5 years of Construction in Progress data on file, last reported at $19747.0 in Q3 2015.
- Quarterly Construction in Progress fell 99.84% year-over-year to $19747.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $19747.0 (down 99.84% YoY) and the FY2014 annual result came in at $5848.0, down 99.98% from the prior year.
- Construction in Progress climbed to $19747.0 in Q3 2015, from $5896.0 in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $29.7 million in Q2 2014 to a low of $5848.0 in Q4 2014.
- A 5-year average of $8.8 million and a median of $3.7 million in 2012 frame the typical range for Construction in Progress.
- Annual changes were most pronounced in 2013 — Construction in Progress surged 4227.86% — and 2015, when it plunged 99.98%.
- Tracing CPHI's Construction in Progress over 5 years: stood at $351571.0 in 2011, then jumped by 949.17% to $3.7 million in 2012, then soared by 591.26% to $25.5 million in 2013, then plunged by 99.98% to $5848.0 in 2014, then surged by 237.67% to $19747.0 in 2015.
- The last three Construction in Progress figures came in at $19747.0 (Q3 2015), $5896.0 (Q2 2015), and $5876.0 (Q1 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 19,747.00 |
| Jun 30, 2015 | 5,896.00 |
| Mar 31, 2015 | 5,876.00 |
| Dec 31, 2014 | 5,848.00 |
| Sep 30, 2014 | 12.54 Mn |
| Jun 30, 2014 | 29.72 Mn |
| Mar 31, 2014 | 29.01 Mn |
| Dec 31, 2013 | 25.50 Mn |
| Sep 30, 2013 | 15.67 Mn |
| Jun 30, 2013 | 10.34 Mn |
| Mar 31, 2013 | 4.13 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Sep 30, 2012 | 361,999.00 |
| Jun 30, 2012 | 354,034.00 |
| Dec 31, 2011 | 351,571.00 |